Injective (INJ) Coin has been garnering a lot of attention in the recent news. Amidst promising
price predictions, the crypto has been the subject of considerable discussion amongst investment forums. As a key player in the
Crypto 2025 outlook, the coin has been highlighted as one of the top 21 to invest in August 2025, with a predicted test of the $12.20 support.
Canary Capital has filed to list a
staked Injective ETF, which has seen the price of the coin spike and could potentially lead to a 100% rally. The developments continue with news of an EVM testnet launch and the return of significant on-chain usage, indicating a surge in the coin's potential in the coming days.
In addition, an Injective protocol filed for
INJ staked ETF for institutional adoption and there are speculations it could reach $16. Further news suggests that
BBVA and
Deutsche Telekom are backing the coin, with the latter speculating a price reversal. The coin hit a 3,000% year-to-date gain after a significant jump in value, leading to debates about its credibility as a Layer One blockchain. Despite a bearish trend and a 70% price drop,
INJ remains a focal point in ongoing conversations about the future of cryptocurrency. Finally, amid rumours of a token burn in December, the outlook for
INJ remains speculative but undeniably fascinating.
INJ Coin News Analytics from Mon, 20 Nov 2017 05:41:38 GMT to Mon, 11 Aug 2025 18:22:56 GMT -
Rating 7
- Innovation 8
- Information 7
- Rumor 6
